From: Clinical outcomes of seasonal influenza and pandemic influenza A (H1N1) in pediatric inpatients
Seasonal influenza | nH1N1 influenza | p-value | |
---|---|---|---|
None | 35 (26%) | 24(18%) | .14 |
Obesity † | 49 (46%) | 51(45%) | 1.00 |
Asthma | 20 (15%) | 40 (30%) | < .01 |
Sickle Cell Disease | 17 (12.8%) | 26 (20%) | .18 |
Neuromuscular Disorder | 24 (18%) | 9 (7%) | < .01 |
Diabetes Mellitus (type 1) | 2 (2%) | 2 (2%) | 1.00 |
Chronic Lung Disease | 15 (11%) | 15 (11%) | 1.00 |
Malignancy | 13 (10%) | 11(8%) | .83 |
Immunodeficiency †† | 10 (8%) | 4 (3%) | .17 |
Prematurity (24-37 w) | 5 (4%) | 10 (8%) | .29 |
Cardiac disorder | 8 (6%) | 5 (4%) | .57 |
Metabolic disorder | 7 (5%) | 7 (5%) | 1.00 |
Renal Failure | 3 (2%) | 1 (1%) | .62 |
Cystic Fibrosis | 4 (3%) | 3 (2%) | 1.00 |